Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc

<< Previous

Bullboard Posts

Next >>

Post by shareswapperon Apr 08, 2020 4:47pm

220 Views

Post# 30891843

Took a Half Million Today

Was shooting for a Million but couldn't get fill. This stock is a Phase II / Phase III company with a multi billion partner. We are doing volume for a reason, make no bones about it. Something is happening behind the scenes. We have a new CEO is Jarosz and a new President in Kloppy. Both have a major stake in sucess here. They are here to shake things up and get us moving. You know they are working it double time. Hang tight Longs, today was "pull back" day, tomorrow we move ....

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project